Crossmark

Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold

Crossref DOI link: https://doi.org/10.1016/j.jcin.2014.06.016

Published Print: 2014-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Onuma, Yoshinobu

Serruys, Patrick W.

Muramatsu, Takashi

Nakatani, Shimpei

van Geuns, Robert-Jan

de Bruyne, Bernard

Dudek, Dariusz

Christiansen, Evald

Smits, Pieter C.

Chevalier, Bernard

McClean, Dougal

Koolen, Jacques

Windecker, Stephan

Whitbourn, Robert

Meredith, Ian

Garcia-Garcia, Hector M.

Veldhof, Susan

Rapoza, Richard

Ormiston, John A.
Funding

Funding for this research was provided by:

Abbott Vascular

Pfizer

Medtronic

St. Jude Medical
License Information

Text and Data Mining valid from 2014-12-01

Text and Data Mining valid from 2014-12-01

Version of Record valid from 2015-12-01
More Information

This article is maintained by: Elsevier

Article Title: Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold

Journal Title: JACC: Cardiovascular Interventions

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jcin.2014.06.016

Content Type: article

Copyright: Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Document is current

Any future updates will be listed below